Health Care & Hospital Law,
Mergers & Acquisitions
Jan. 31, 2024
A new era in California health care M&A
Though it is too early to tell how aggressive the California Office of Health Care Affordability will be in subjecting transactions to a full review, the regulations will consider the anticompetitive impact and potential negative impact on health care costs or availability.
California healthcare transactions closing on or after April 1, 2024 could be subject to a nine month or greater delay under the cost and market impact review (CMIR) regulations recently promulgated by the newly created California Office of Health Care Affordability (OHCA).
1. Applicability
The applicability of CMIR to a given transaction boils down to three questions: Does the transaction involve a health care...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In